These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6104790)

  • 41. Phase II study of cisplatin therapy in patients with metastatic carcinoid tumor and the malignant carcinoid syndrome.
    Moertel CG; Rubin J; O'Connell MJ
    Cancer Treat Rep; 1986 Dec; 70(12):1459-60. PubMed ID: 3791259
    [No Abstract]   [Full Text] [Related]  

  • 42. Carcinoid syndrome in bronchogenic carcinoma.
    Majcher SJ; Lee ER; Reingold IM; Boyle J; Haverback BJ
    Arch Intern Med; 1966 Jan; 117(1):57-63. PubMed ID: 5900490
    [No Abstract]   [Full Text] [Related]  

  • 43. [Anesthesia and intensive care in secreting digestive carcinoid tumors].
    Desmonts JM; Ribier AD; Gilles MR; Vic Dupont P
    Anesth Analg (Paris); 1978; 35(1):143-53. PubMed ID: 677494
    [No Abstract]   [Full Text] [Related]  

  • 44. [Carcinoid syndrome].
    Li D; Cheng Y
    Zhonghua Wai Ke Za Zhi; 1995 Apr; 33(4):246-8. PubMed ID: 7587683
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of carcinoid syndrome with a somatostatin analogue].
    Döbrönte Z; Stöckert A; Végh G; Varga L
    Orv Hetil; 1992 Mar; 133(12):731-4. PubMed ID: 1372969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of combined cyclophosphamide and methotrexate therapy in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome.
    Moertel CG; O'Connell MJ; Reitemeier RJ; Rubin J
    Cancer Treat Rep; 1984 Apr; 68(4):665-7. PubMed ID: 6201271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Enteral hyperoxalosis due to therapy with a somatostatin analog].
    Ranft K; Eibl-Eibesfeldt B
    Dtsch Med Wochenschr; 1990 Feb; 115(5):179-81. PubMed ID: 2298134
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The carcinoid syndrome with a report of metastasizing bronchial carcinoid].
    GRAMLICH F; WIETHOFF EO
    Dtsch Med Wochenschr; 1960 Sep; 85():1750-6. PubMed ID: 13707777
    [No Abstract]   [Full Text] [Related]  

  • 49. [Serious vascular complications in malignant carcinoid tumor].
    Estrada Sáiz RV; Sánchez de las Matas Sánchez I; García Paredes J
    An Med Interna; 1989 Oct; 6(10):534-6. PubMed ID: 2491049
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Somatostatin and a long-acting analogue, octreotide acetate. Relevance to dermatology.
    Camisa C
    Arch Dermatol; 1989 Mar; 125(3):407-12. PubMed ID: 2564269
    [No Abstract]   [Full Text] [Related]  

  • 51. [Bronchospastic syndrome in acute pneumonia].
    Iakovlev VN; Khizhniak AA; Alekseev VG; Gerasimov GM; Logunov OV
    Sov Med; 1984; (8):72-5. PubMed ID: 6495000
    [No Abstract]   [Full Text] [Related]  

  • 52. Long-term management of the carcinoid syndrome. Treatment with octreotide alone and in combination with alpha-interferon.
    Janson ET; Oberg K
    Acta Oncol; 1993; 32(2):225-9. PubMed ID: 7686765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of carcinoid syndrome.
    Bonomi P; Hovey C; Dainauskas JR; Slayton R; Wolter J
    Med Pediatr Oncol; 1979; 6(1):77-83. PubMed ID: 440207
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The carcinoid syndrome and angioedema.
    Wymenga AN; de Monchy JG; de Vries EG
    Ann Intern Med; 1995 Oct; 123(8):636. PubMed ID: 7677314
    [No Abstract]   [Full Text] [Related]  

  • 55. Atropine effects on antigen-mediated airway constriction.
    Crehek J; Gayrard P
    Am Rev Respir Dis; 1977 Oct; 116(4):792-4. PubMed ID: 921059
    [No Abstract]   [Full Text] [Related]  

  • 56. The management of refractory carcinoid syndrome: challenges and opportunities ahead.
    Cives M; Pellè E; Silvestris F
    J Med Econ; 2018 Mar; 21(3):241-243. PubMed ID: 29039712
    [No Abstract]   [Full Text] [Related]  

  • 57. Airways obstruction in the carcinoid syndrome. A study of the effect of drugs and other factors. I. Clinical and laboratory findings.
    Turck WP; Zeitlin IJ; Smith AN; Grant IW
    Scott Med J; 1972 Jul; 17(7):237-43. PubMed ID: 5041785
    [No Abstract]   [Full Text] [Related]  

  • 58. Assessment of serotonin concentration in patients with a small-intestine neuroendocrine neoplasm and carcinoid syndrome treated with somatostatin analogues.
    Gut P; Czarnywojtek A; Sawicka-Gutaj N; Ruchała M
    Pol Arch Intern Med; 2020 Oct; 130(10):903-905. PubMed ID: 32643913
    [No Abstract]   [Full Text] [Related]  

  • 59. Airways obstruction in the carcinoid syndrome. A study of the effect of drugs and other factors. II. Investigation of reversible airways obstruction.
    Turck WP; Grant IW; Zeitlin IJ; Smith AN
    Scott Med J; 1972 Jul; 17(7):244-51. PubMed ID: 4114411
    [No Abstract]   [Full Text] [Related]  

  • 60. Tamoxifen in carcinoid syndrome.
    Stathopoulos GP; Karvountzis GG; Yiotis J
    N Engl J Med; 1981 Jul; 305(1):52. PubMed ID: 7231519
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.